泡沫硬化剂治疗静脉畸形的新进展  

New progress on foam sclerotherapy in treatment of venous malformations

作　　者：周怡彤 黄熙[1] 

机构地区：[1]桂林医学院,广西桂林541004

出　　处：《华夏医学》2017年第6期150-153,共4页Acta Medicinae Sinica

摘　　要：静脉畸形(Venous malformations,VMs)是临床常见的脉管畸形,幼年时即可发病,随着年龄的增长而逐渐增大,不能自行消退,常影响美观,需尽早干预治疗。泡沫硬化剂(sclerosant foam)由于其延长了与血管内皮细胞的接触时间,并减少了硬化剂的剂量,降低硬化剂注射引起的不良反应,因此,泡沫硬化疗法(foam sclerotherapy)成为目前静脉畸形治疗的主要方法,现就泡沫硬化剂治疗静脉畸形的新进展作一综述。Venous malformation is common blood vessel malformation in clinic. In early childhood, it may happen and increases gradually along with the age growth, cannot abate voluntarily, and often affects artisticly. Therefore it must be treated as soon as possible. Because the selerosant foam lengthened with the blood vessel endothelial cell contact duration, and reduce the selerosant foam dosage, reduces side effect of the selerosant foam injection, the foam selerotherapy has become the main treatment method for this disease. Author reviews the new progress on foam sclerotherapy in treatment of venous malformations .

关 键 词：静脉畸形 泡沫硬化剂 泡沫硬化疗法 

分 类 号：R543.6[医药卫生—心血管疾病]